Rosalind Franklin Society Proudly Announces the 2022 Award Recipient for Clinical Thyroidology

Clinical Thyroidology®Vol. 35, No. 8 AnnouncementFree AccessRosalind Franklin Society Proudly Announces the 2022 Award Recipient for Clinical ThyroidologyElizabeth McAninchElizabeth McAninchStanford University, School of Medicine, Stanford, CA, USASearch for more papers by this authorPublished Online:16 Aug 2023https://doi.org/10.1089/ct.2023;35.307-307AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail The Rosalind Franklin Society (RFS), in partnership with Mary Ann Liebert, Inc., publishers, enthusiastically congratulate our distinguished recipient of the 2022 annualRFS Award in Sciencefor this journal, which recognizes the outstanding research and published work of women and underrepresented minority scientists, physicians, and engineers.As an established expert in this field, Dr. Elizabeth McAninch's clinical and research interests are focused on the diagnosis and management of hypothyroidism. She has authored the following reviews in Clinical Thyroidology during 2022 which have contributed to the understanding of this topic. Elizabeth A. McAninch, “Phase 1 Clinical Trial of Poly‐Zinc‐Liothyronine Demonstrates Slow‐Release Serum T3 Kinetics,” Clinical Thyroidology 34, no. 1 (January 2022): 9–12.Elizabeth A. McAninch, “Association of Hypothyroidism with Depression May Be Dependent on the Severity of Hypothyroidism and Stronger in Females,” Clinical Thyroidology 34, no. 3 (March 2022):109–111.Elizabeth A. McAninch, “Hypothyroidism Is Common Among Childhood Cancer Survivors,” Clinical Thyroidology 34, no. 5 (May 2022): 196–198.Elizabeth A. McAninch, “Switching Generic‐to‐Generic Levothyroxine Does Not Change Serum TSH,” Clinical Thyroidology 34, no. 7 (July 2022): 295–297.Elizabeth A. McAninch, “Objective Markers of Thyroid Hormone Homeostasis in Levothyroxine Versus Liothyronine Monotherapies,” Clinical Thyroidology 34, no. 9 (September 2022): 389–391.Elizabeth A. McAninch, “How Should I Take My Levothyroxine?” Clinical Thyroidology 34, no. 11 (November 2022): 483–486.BiosketchDr. Elizabeth A. McAninch is a clinical associate professor of medicine in the Division of Endocrinology, Gerontology, and Metabolism in the Department of Medicine at Stanford University Medical Center. She has a BA with Highest Honors in mathematics from Smith College and earned her MD at the University of Miami Miller School of Medicine. She then completed her internal medicine residency and endocrinology fellowship at the University of Miami/Jackson Memorial Hospital. In her early career, her research focused on thyroid hormone metabolism and action with translational applications aiming to preserve thyroid hormone homeostasis in patients with hypothyroidism. At Stanford, her clinical practice focuses on functional and structural thyroidology, as well as management of other endocrine neoplasia. She has ongoing research interests in the fields of endocrinology, metabolism, and aging.FiguresReferencesRelatedDetails Volume 35Issue 8Aug 2023 Information© Copyright 2023, Mary Ann Liebert, Inc.To cite this article:Elizabeth McAninch.Rosalind Franklin Society Proudly Announces the 2022 Award Recipient for Clinical Thyroidology.Clinical Thyroidology®.Aug 2023.307-307.http://doi.org/10.1089/ct.2023;35.307-307Published in Volume: 35 Issue 8: August 16, 2023PDF download